Solution structures of the antifungal heliomicin and a selected variant with both antibacterial and antifungal

M Lamberty1, A Caille, C Landon

  • 1Institut de Biologie Moléculaire et Cellulaire, Unité Propre de Recherche 9022, CNRS, "Réponse Immunitaire et Développement chez les Insectes", 15 rue René Descartes, 67084 Strasbourg Cedex, France.

Biochemistry
|October 3, 2001
PubMed

Insights

Heliomicin, an antifungal protein from Heliothis virescens, was studied to understand its structural basis for activity. Mutations revealed a variant with enhanced antibacterial and retained antifungal properties, aiding future antimicrobial peptide design.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Structural Biology

Background:

  • The insect Heliothis virescens produces heliomicin, an antifungal protein with sequence similarities to plant and insect defensins.
  • Understanding the structural determinants of heliomicin's activity is crucial for developing novel antimicrobial agents.

Purpose of the Study:

  • To investigate the structural elements responsible for heliomicin's antifungal and antibacterial activities.
  • To correlate structural modifications with changes in antimicrobial efficacy.
  • To guide the design of new heliomicin variants with improved antibacterial properties.

Main Methods:

  • Expression of wild-type heliomicin and point-mutated variants in yeast as fusion proteins.
  • Antimicrobial assays (antibacterial and antifungal) to evaluate the activity of protein variants.
  • Three-dimensional structure determination of wild-type and a potent variant using 2D (1)H NMR spectroscopy.

Main Results:

  • A heliomicin variant demonstrated significant activity against Gram-positive bacteria while maintaining antifungal efficacy.
  • Both wild-type and mutated heliomicins share a common cysteine-stabilized alpha/beta scaffold.
  • Structural comparison revealed common hydrophobic characteristics in antifungal defensins and identified features associated with antibacterial activity.

Conclusions:

  • Structural analysis of heliomicin variants provides insights into the structure-activity relationships of insect defensins.
  • The study facilitates the rational design of novel antimicrobial peptides with tailored activity spectra.
  • Targeted mutations can enhance the antibacterial potency of heliomicin while preserving its antifungal function.

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...